Total planned funding: $503,948,568
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $86,426,108 |
| Kenya | $72,311,403 |
| South Africa | $69,793,039 |
| Tanzania | $53,565,418 |
| Mozambique | $52,208,382 |
| Ethiopia | $31,983,158 |
| Zambia | $17,761,706 |
| Haiti | $17,596,125 |
| Uganda | $13,144,604 |
| Malawi | $12,725,000 |
| Botswana | $12,638,139 |
| Rwanda | $10,706,108 |
| Eswatini | $10,621,120 |
| Democratic Republic of the Congo | $8,530,638 |
| Namibia | $7,853,878 |
| Côte d'Ivoire | $7,116,000 |
| Vietnam | $4,094,999 |
| Guyana | $3,120,000 |
| Lesotho | $3,000,000 |
| Angola | $2,450,000 |
| Caribbean Region | $2,080,000 |
| Zimbabwe | $1,125,000 |
| India | $1,100,000 |
| Central Asia Region | $927,743 |
| Ghana | $670,000 |
| Burundi | $300,000 |
| Dominican Republic | $100,000 |
| Russia | $0 |
| China | $0 |
Organizational Types
| University | $503,948,568 |
Program Areas
| Treatment | $142,428,656 |
| Governance and Systems | $82,156,289 |
| Prevention | $77,079,281 |
| Care | $60,593,852 |
| Testing | $10,761,789 |
| Management and Operations | $210,000 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $119,042,909 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $39,706,716 |
| HVSI: Strategic Information | $36,178,051 |
| OHSS: Health Systems Strengthening | $28,015,179 |
| HBHC: Care: Adult Care and Support | $27,695,271 |
| HVTB: Care: TB/HIV | $20,942,928 |
| PDTX: Treatment: Pediatric Treatment | $20,168,461 |
| HLAB: Laboratory Infrastructure | $17,963,059 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $12,927,845 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $12,213,022 |
| HVCT: Testing: HIV Testing and Counseling | $10,761,789 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $9,272,175 |
| PDCS: Care: Pediatric Care and Support | $7,805,557 |
| HKID: Care: Orphans and Vulnerable Children | $4,150,096 |
| HTXD: Treatment: ARV Drugs | $3,217,286 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,881,385 |
| HMBL: Biomedical Prevention: Blood Safety | $545,302 |
| HMIN: Biomedical Prevention: Injection Safety | $532,836 |
| HVMS: Management and Operations | $210,000 |